Sol-Gel Technologies Ltd.
Develops and commercializes topical dermatology drugs for acne, rosacea, and rare skin conditions.
SLGL | US
Overview
Corporate Details
- ISIN(s):
- IL0011417206
- LEI:
- Country:
- United States of America
- Address:
- 7 GOLDA MEIR ST., 7403648 NESS ZIONA
- Website:
- http://www.sol-gel.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sol-Gel Technologies Ltd. is a dermatology company engaged in the identification, development, and commercialization of topical drug products. The company has developed FDA-approved treatments, including Twyneo® for acne vulgaris and Epsolay® for inflammatory lesions of rosacea. Its clinical-stage pipeline focuses on delivering innovative treatments for rare skin conditions, with a lead candidate, patidegib gel, designed to prevent new basal cell carcinoma lesions in patients with Gorlin syndrome. Sol-Gel aims to address unmet patient needs by developing novel formulations that surpass the current standard of care in medical dermatology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Sol-Gel Technologies Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sol-Gel Technologies Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sol-Gel Technologies Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
